Denise Zamore - Apr 1, 2025 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Legal Officer
Signature
/s/ Mimi Yang, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Apr 1, 2025
Transactions value $
$0
Form type
4
Date filed
4/3/2025, 07:39 PM
Previous filing
Mar 24, 2025
Next filing
Apr 16, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +245K +119.59% $0.00 450K Apr 1, 2025 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Right to buy) Award $0 +385K $0.00 385K Apr 1, 2025 Common Stock 385K $4.08 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.
F2 Includes Performance Stock Units which may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date.
F3 Includes restricted stock units.
F4 Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.